Diabetes is on the rise all over the world and work is being done in various fields for its treatment, one of which is a new development in the form of ultrasound.
A joint study by experts from various US research institutes and universities in the latest issue of the research journal Nature Biomedical Engineering shows that the amount of insulin and sugar in the blood of animals can be determined by focusing ultrasound waves on certain nerves in the liver for only three minutes. Significantly decreased. These experiments were performed on mice and pigs.
Research has shown that portal hepatitis, a part of the liver, contains a nerve clot called the hepatoportal nerve plexus, which transmits information to the brain about glucose and nutritional status. Both glucose and insulin levels fluctuate, while the nerve endings are so small that it is difficult to control their activity from the outside. This technique emerged a few years ago as a new possibility.
Raymond Herzog, a Yale School of Medicine endocrinologist working on the project, explained that ultrasound neuromodulation would be an exciting and completely new addition to the treatment of our patients if ongoing clinical trials confirmed the research.
We are now in the midst of human feasibility trials with a group of subjects with type 2 diabetes who are beginning to move towards clinical translation using ultrasound said Christopher Plio, author of the new study and senior biomedical engineer at GE Research. It could be a game changer in how biotechnologies are used and applied to diseases like type 2 diabetes in the future.